Nafarelin in the treatment of infertility caused by endometriosis.
Where this comes from
- Record sourced from PubMed, PMID 2137973.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with infertility caused by endometriosis may be managed by expectant strategies, surgery, or pharmacologic intervention. The relative benefits conferred by each of these approaches remain to be confirmed. Data gathered thus far suggest, however, that nafarelin, a gonadotropin-releasing hormone agonist, may be associated with fecundity rates as low as those seen after surgical intervention.
Medical subject headings
- Endometriosis
- Gonadotropin-Releasing Hormone
- Infertility, Female